Vyvanse Sales Data

Rank 27 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Vyvanse U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 27 (2) 9.39% 8.70%
Q3 2013 29 (1) 1.65% -5.31%
Q2 2013 28 (1) -6.66% -7.49%
Q1 2013 27 (1) 5.48% -2.75%
Q4 2012 28 (7) 11.92% 11.75%
Q3 2012 35 (3) -2.81% -2.60%
Q2 2012 38 (2) -3.00% -2.78%
Q1 2012 40 (3) 11.05% 4.08%
Q4 2011 43 (2) 13.05% 13.26%
Q3 2011 45 (1) 1.08% 1.51%
Q2 2011 44 (5) -1.39% -1.49%
Q1 2011 49

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
November 15, 2010Vyvanse Approved for Adolescent ADHD
Hide
(web2)